These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 24184036

  • 1. Influence of drug physicochemical properties on absorption of water insoluble drug nanosuspensions.
    Li W, Quan P, Zhang Y, Cheng J, Liu J, Cun D, Xiang R, Fang L.
    Int J Pharm; 2014 Jan 02; 460(1-2):13-23. PubMed ID: 24184036
    [Abstract] [Full Text] [Related]

  • 2. Preparation and in vitro/in vivo evaluation of revaprazan hydrochloride nanosuspension.
    Li W, Yang Y, Tian Y, Xu X, Chen Y, Mu L, Zhang Y, Fang L.
    Int J Pharm; 2011 Apr 15; 408(1-2):157-62. PubMed ID: 21295124
    [Abstract] [Full Text] [Related]

  • 3. Nanonization of itraconazole by high pressure homogenization: stabilizer optimization and effect of particle size on oral absorption.
    Sun W, Mao S, Shi Y, Li LC, Fang L.
    J Pharm Sci; 2011 Aug 15; 100(8):3365-3373. PubMed ID: 21520089
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Investigation of nanosized crystalline form to improve the oral bioavailability of poorly water soluble cilostazol.
    Miao X, Sun C, Jiang T, Zheng L, Wang T, Wang S.
    J Pharm Pharm Sci; 2011 Aug 15; 14(2):196-214. PubMed ID: 21733409
    [Abstract] [Full Text] [Related]

  • 6. Formulation and Evaluation of Naringenin Nanosuspensions for Bioavailability Enhancement.
    Gera S, Talluri S, Rangaraj N, Sampathi S.
    AAPS PharmSciTech; 2017 Nov 15; 18(8):3151-3162. PubMed ID: 28534300
    [Abstract] [Full Text] [Related]

  • 7. Diclofenac nanosuspensions: influence of preparation procedure and crystal form on drug dissolution behaviour.
    Lai F, Sinico C, Ennas G, Marongiu F, Marongiu G, Fadda AM.
    Int J Pharm; 2009 May 21; 373(1-2):124-32. PubMed ID: 19429297
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Enhanced dissolution and oral bioavailability of aripiprazole nanosuspensions prepared by nanoprecipitation/homogenization based on acid-base neutralization.
    Xu Y, Liu X, Lian R, Zheng S, Yin Z, Lu Y, Wu W.
    Int J Pharm; 2012 Nov 15; 438(1-2):287-95. PubMed ID: 22989976
    [Abstract] [Full Text] [Related]

  • 10. Effects of stabilizing agents on the development of myricetin nanosuspension and its characterization: an in vitro and in vivo evaluation.
    Hong C, Dang Y, Lin G, Yao Y, Li G, Ji G, Shen H, Xie Y.
    Int J Pharm; 2014 Dec 30; 477(1-2):251-60. PubMed ID: 25445518
    [Abstract] [Full Text] [Related]

  • 11. Effect of crystal size on the in vitro dissolution and oral absorption of nitrendipine in rats.
    Xia D, Cui F, Piao H, Cun D, Piao H, Jiang Y, Ouyang M, Quan P.
    Pharm Res; 2010 Sep 30; 27(9):1965-76. PubMed ID: 20585842
    [Abstract] [Full Text] [Related]

  • 12. Development of novel polymer-stabilized diosmin nanosuspensions: in vitro appraisal and ex vivo permeation.
    Freag MS, Elnaggar YS, Abdallah OY.
    Int J Pharm; 2013 Sep 15; 454(1):462-71. PubMed ID: 23830765
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Increased dissolution and oral absorption of itraconazole/Soluplus extrudate compared with itraconazole nanosuspension.
    Zhang K, Yu H, Luo Q, Yang S, Lin X, Zhang Y, Tian B, Tang X.
    Eur J Pharm Biopharm; 2013 Nov 15; 85(3 Pt B):1285-92. PubMed ID: 23562534
    [Abstract] [Full Text] [Related]

  • 15. Preparation and in vitro/in vivo evaluation of fenofibrate nanocrystals.
    Zuo B, Sun Y, Li H, Liu X, Zhai Y, Sun J, He Z.
    Int J Pharm; 2013 Oct 15; 455(1-2):267-75. PubMed ID: 23876497
    [Abstract] [Full Text] [Related]

  • 16. Improved Oral Bioavailability of Lacidipine Using Nanosuspension Technology: Inferior in vitro Dissolution and Superior in vivo Drug Absorption versus Lacipil®.
    Zhao J, Luo L, Fu Q, Guo B, Li Y, Geng Y, Wang J, Zhang T.
    Curr Drug Deliv; 2016 Oct 15; 13(5):764-73. PubMed ID: 25963306
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Preparation, characterization and in vivo evaluation of amorphous tacrolimus nanosuspensions produced using CO2-assisted in situ nanoamorphization method.
    Wang Y, Han X, Wang J, Wang Y.
    Int J Pharm; 2016 May 30; 505(1-2):35-41. PubMed ID: 27034003
    [Abstract] [Full Text] [Related]

  • 20. Dermal flurbiprofen nanosuspensions: Optimization with design of experiment approach and in vitro evaluation.
    Oktay AN, Karakucuk A, Ilbasmis-Tamer S, Celebi N.
    Eur J Pharm Sci; 2018 Sep 15; 122():254-263. PubMed ID: 29981401
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.